nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—CYP2C19—Teniposide—lymphatic system cancer	0.0506	0.457	CbGbCtD
Doxazosin—ABCB1—Mitoxantrone—lymphatic system cancer	0.0285	0.258	CbGbCtD
Doxazosin—ABCB1—Vincristine—lymphatic system cancer	0.0196	0.178	CbGbCtD
Doxazosin—ABCB1—Methotrexate—lymphatic system cancer	0.0119	0.108	CbGbCtD
Doxazosin—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00147	0.00165	CcSEcCtD
Doxazosin—Asthenia—Teniposide—lymphatic system cancer	0.00146	0.00164	CcSEcCtD
Doxazosin—Cystitis noninfective—Methotrexate—lymphatic system cancer	0.00145	0.00163	CcSEcCtD
Doxazosin—Melaena—Methotrexate—lymphatic system cancer	0.00145	0.00163	CcSEcCtD
Doxazosin—Malaise—Bleomycin—lymphatic system cancer	0.00145	0.00163	CcSEcCtD
Doxazosin—Pruritus—Teniposide—lymphatic system cancer	0.00144	0.00162	CcSEcCtD
Doxazosin—Arrhythmia—Carmustine—lymphatic system cancer	0.00144	0.00161	CcSEcCtD
Doxazosin—Leukopenia—Bleomycin—lymphatic system cancer	0.00144	0.00161	CcSEcCtD
Doxazosin—Cystitis—Methotrexate—lymphatic system cancer	0.00143	0.00161	CcSEcCtD
Doxazosin—Alopecia—Carmustine—lymphatic system cancer	0.00142	0.0016	CcSEcCtD
Doxazosin—Body temperature increased—Fludarabine—lymphatic system cancer	0.00141	0.00159	CcSEcCtD
Doxazosin—Mental disorder—Carmustine—lymphatic system cancer	0.00141	0.00158	CcSEcCtD
Doxazosin—Malnutrition—Carmustine—lymphatic system cancer	0.0014	0.00157	CcSEcCtD
Doxazosin—Cough—Bleomycin—lymphatic system cancer	0.0014	0.00157	CcSEcCtD
Doxazosin—Diarrhoea—Teniposide—lymphatic system cancer	0.00139	0.00156	CcSEcCtD
Doxazosin—Chest pain—Bleomycin—lymphatic system cancer	0.00137	0.00153	CcSEcCtD
Doxazosin—Myalgia—Bleomycin—lymphatic system cancer	0.00137	0.00153	CcSEcCtD
Doxazosin—Alopecia—Vincristine—lymphatic system cancer	0.00136	0.00152	CcSEcCtD
Doxazosin—Back pain—Carmustine—lymphatic system cancer	0.00135	0.00152	CcSEcCtD
Doxazosin—Discomfort—Bleomycin—lymphatic system cancer	0.00135	0.00152	CcSEcCtD
Doxazosin—Mental disorder—Vincristine—lymphatic system cancer	0.00134	0.00151	CcSEcCtD
Doxazosin—Chills—Mitoxantrone—lymphatic system cancer	0.00134	0.00151	CcSEcCtD
Doxazosin—Urine output increased—Methotrexate—lymphatic system cancer	0.00134	0.00151	CcSEcCtD
Doxazosin—Bladder pain—Methotrexate—lymphatic system cancer	0.00134	0.00151	CcSEcCtD
Doxazosin—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00134	0.0015	CcSEcCtD
Doxazosin—Gynaecomastia—Methotrexate—lymphatic system cancer	0.00133	0.00149	CcSEcCtD
Doxazosin—Alopecia—Mitoxantrone—lymphatic system cancer	0.00132	0.00148	CcSEcCtD
Doxazosin—Confusional state—Bleomycin—lymphatic system cancer	0.00132	0.00148	CcSEcCtD
Doxazosin—Vision blurred—Carmustine—lymphatic system cancer	0.00132	0.00148	CcSEcCtD
Doxazosin—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00131	0.00148	CcSEcCtD
Doxazosin—Tremor—Carmustine—lymphatic system cancer	0.00131	0.00147	CcSEcCtD
Doxazosin—Oedema—Bleomycin—lymphatic system cancer	0.00131	0.00147	CcSEcCtD
Doxazosin—Infection—Bleomycin—lymphatic system cancer	0.0013	0.00146	CcSEcCtD
Doxazosin—Back pain—Vincristine—lymphatic system cancer	0.00129	0.00145	CcSEcCtD
Doxazosin—Vomiting—Teniposide—lymphatic system cancer	0.00129	0.00145	CcSEcCtD
Doxazosin—Sepsis—Methotrexate—lymphatic system cancer	0.00129	0.00145	CcSEcCtD
Doxazosin—Agitation—Carmustine—lymphatic system cancer	0.00129	0.00145	CcSEcCtD
Doxazosin—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00128	0.00144	CcSEcCtD
Doxazosin—Asthenia—Fludarabine—lymphatic system cancer	0.00128	0.00144	CcSEcCtD
Doxazosin—Rash—Teniposide—lymphatic system cancer	0.00128	0.00144	CcSEcCtD
Doxazosin—Dermatitis—Teniposide—lymphatic system cancer	0.00128	0.00144	CcSEcCtD
Doxazosin—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00127	0.00143	CcSEcCtD
Doxazosin—Headache—Teniposide—lymphatic system cancer	0.00127	0.00143	CcSEcCtD
Doxazosin—Pruritus—Fludarabine—lymphatic system cancer	0.00126	0.00142	CcSEcCtD
Doxazosin—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.00126	0.00142	CcSEcCtD
Doxazosin—Back pain—Mitoxantrone—lymphatic system cancer	0.00126	0.00142	CcSEcCtD
Doxazosin—Leukopenia—Carmustine—lymphatic system cancer	0.00125	0.00141	CcSEcCtD
Doxazosin—Anorexia—Bleomycin—lymphatic system cancer	0.00125	0.0014	CcSEcCtD
Doxazosin—Agitation—Vincristine—lymphatic system cancer	0.00123	0.00138	CcSEcCtD
Doxazosin—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00123	0.00138	CcSEcCtD
Doxazosin—Polyuria—Methotrexate—lymphatic system cancer	0.00123	0.00138	CcSEcCtD
Doxazosin—Hypotension—Bleomycin—lymphatic system cancer	0.00122	0.00137	CcSEcCtD
Doxazosin—Diarrhoea—Fludarabine—lymphatic system cancer	0.00122	0.00137	CcSEcCtD
Doxazosin—Convulsion—Carmustine—lymphatic system cancer	0.00121	0.00136	CcSEcCtD
Doxazosin—Hypertension—Carmustine—lymphatic system cancer	0.00121	0.00136	CcSEcCtD
Doxazosin—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00121	0.00136	CcSEcCtD
Doxazosin—Nausea—Teniposide—lymphatic system cancer	0.00121	0.00136	CcSEcCtD
Doxazosin—Vertigo—Vincristine—lymphatic system cancer	0.0012	0.00135	CcSEcCtD
Doxazosin—Leukopenia—Vincristine—lymphatic system cancer	0.0012	0.00134	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00119	0.00134	CcSEcCtD
Doxazosin—Chest pain—Carmustine—lymphatic system cancer	0.00119	0.00134	CcSEcCtD
Doxazosin—Myalgia—Carmustine—lymphatic system cancer	0.00119	0.00134	CcSEcCtD
Doxazosin—Anxiety—Carmustine—lymphatic system cancer	0.00119	0.00134	CcSEcCtD
Doxazosin—Paraesthesia—Bleomycin—lymphatic system cancer	0.00118	0.00132	CcSEcCtD
Doxazosin—Malaise—Mitoxantrone—lymphatic system cancer	0.00117	0.00132	CcSEcCtD
Doxazosin—Dyspnoea—Bleomycin—lymphatic system cancer	0.00117	0.00131	CcSEcCtD
Doxazosin—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00116	0.00131	CcSEcCtD
Doxazosin—Convulsion—Vincristine—lymphatic system cancer	0.00116	0.0013	CcSEcCtD
Doxazosin—Hypertension—Vincristine—lymphatic system cancer	0.00115	0.0013	CcSEcCtD
Doxazosin—Confusional state—Carmustine—lymphatic system cancer	0.00115	0.00129	CcSEcCtD
Doxazosin—Oedema—Carmustine—lymphatic system cancer	0.00114	0.00128	CcSEcCtD
Doxazosin—Decreased appetite—Bleomycin—lymphatic system cancer	0.00114	0.00128	CcSEcCtD
Doxazosin—Myalgia—Vincristine—lymphatic system cancer	0.00114	0.00128	CcSEcCtD
Doxazosin—Cough—Mitoxantrone—lymphatic system cancer	0.00114	0.00128	CcSEcCtD
Doxazosin—Infection—Carmustine—lymphatic system cancer	0.00113	0.00128	CcSEcCtD
Doxazosin—Vomiting—Fludarabine—lymphatic system cancer	0.00113	0.00128	CcSEcCtD
Doxazosin—Convulsion—Mitoxantrone—lymphatic system cancer	0.00113	0.00127	CcSEcCtD
Doxazosin—Rash—Fludarabine—lymphatic system cancer	0.00113	0.00127	CcSEcCtD
Doxazosin—Dermatitis—Fludarabine—lymphatic system cancer	0.00112	0.00126	CcSEcCtD
Doxazosin—Hypertension—Mitoxantrone—lymphatic system cancer	0.00112	0.00126	CcSEcCtD
Doxazosin—Pain—Bleomycin—lymphatic system cancer	0.00112	0.00126	CcSEcCtD
Doxazosin—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00112	0.00126	CcSEcCtD
Doxazosin—Headache—Fludarabine—lymphatic system cancer	0.00112	0.00126	CcSEcCtD
Doxazosin—Tachycardia—Carmustine—lymphatic system cancer	0.00111	0.00125	CcSEcCtD
Doxazosin—Myalgia—Mitoxantrone—lymphatic system cancer	0.00111	0.00125	CcSEcCtD
Doxazosin—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00111	0.00125	CcSEcCtD
Doxazosin—Chest pain—Mitoxantrone—lymphatic system cancer	0.00111	0.00125	CcSEcCtD
Doxazosin—Anxiety—Mitoxantrone—lymphatic system cancer	0.0011	0.00124	CcSEcCtD
Doxazosin—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.0011	0.00124	CcSEcCtD
Doxazosin—Discomfort—Mitoxantrone—lymphatic system cancer	0.00109	0.00123	CcSEcCtD
Doxazosin—Oedema—Vincristine—lymphatic system cancer	0.00109	0.00123	CcSEcCtD
Doxazosin—Anorexia—Carmustine—lymphatic system cancer	0.00109	0.00122	CcSEcCtD
Doxazosin—Infection—Vincristine—lymphatic system cancer	0.00108	0.00122	CcSEcCtD
Doxazosin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00108	0.00121	CcSEcCtD
Doxazosin—Confusional state—Mitoxantrone—lymphatic system cancer	0.00107	0.0012	CcSEcCtD
Doxazosin—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00107	0.0012	CcSEcCtD
Doxazosin—Hypotension—Carmustine—lymphatic system cancer	0.00107	0.0012	CcSEcCtD
Doxazosin—Oedema—Mitoxantrone—lymphatic system cancer	0.00106	0.00119	CcSEcCtD
Doxazosin—Nausea—Fludarabine—lymphatic system cancer	0.00106	0.00119	CcSEcCtD
Doxazosin—Infection—Mitoxantrone—lymphatic system cancer	0.00105	0.00119	CcSEcCtD
Doxazosin—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00105	0.00119	CcSEcCtD
Doxazosin—Shock—Mitoxantrone—lymphatic system cancer	0.00104	0.00117	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00104	0.00117	CcSEcCtD
Doxazosin—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00104	0.00117	CcSEcCtD
Doxazosin—Urticaria—Bleomycin—lymphatic system cancer	0.00104	0.00117	CcSEcCtD
Doxazosin—Anorexia—Vincristine—lymphatic system cancer	0.00104	0.00117	CcSEcCtD
Doxazosin—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00104	0.00117	CcSEcCtD
Doxazosin—Body temperature increased—Bleomycin—lymphatic system cancer	0.00103	0.00116	CcSEcCtD
Doxazosin—Insomnia—Carmustine—lymphatic system cancer	0.00103	0.00116	CcSEcCtD
Doxazosin—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00103	0.00116	CcSEcCtD
Doxazosin—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00103	0.00115	CcSEcCtD
Doxazosin—Paraesthesia—Carmustine—lymphatic system cancer	0.00103	0.00115	CcSEcCtD
Doxazosin—Mood swings—Methotrexate—lymphatic system cancer	0.00102	0.00115	CcSEcCtD
Doxazosin—Hypotension—Vincristine—lymphatic system cancer	0.00102	0.00115	CcSEcCtD
Doxazosin—Dyspnoea—Carmustine—lymphatic system cancer	0.00102	0.00114	CcSEcCtD
Doxazosin—Somnolence—Carmustine—lymphatic system cancer	0.00102	0.00114	CcSEcCtD
Doxazosin—Anorexia—Mitoxantrone—lymphatic system cancer	0.00101	0.00114	CcSEcCtD
Doxazosin—Ataxia—Methotrexate—lymphatic system cancer	0.00101	0.00114	CcSEcCtD
Doxazosin—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000994	0.00112	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000993	0.00112	CcSEcCtD
Doxazosin—Decreased appetite—Carmustine—lymphatic system cancer	0.000993	0.00112	CcSEcCtD
Doxazosin—Hypotension—Mitoxantrone—lymphatic system cancer	0.000992	0.00112	CcSEcCtD
Doxazosin—Insomnia—Vincristine—lymphatic system cancer	0.000986	0.00111	CcSEcCtD
Doxazosin—Paraesthesia—Vincristine—lymphatic system cancer	0.000979	0.0011	CcSEcCtD
Doxazosin—Constipation—Carmustine—lymphatic system cancer	0.000977	0.0011	CcSEcCtD
Doxazosin—Pain—Carmustine—lymphatic system cancer	0.000977	0.0011	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000967	0.00109	CcSEcCtD
Doxazosin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000964	0.00108	CcSEcCtD
Doxazosin—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000954	0.00107	CcSEcCtD
Doxazosin—Decreased appetite—Vincristine—lymphatic system cancer	0.000948	0.00107	CcSEcCtD
Doxazosin—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000947	0.00106	CcSEcCtD
Doxazosin—Somnolence—Mitoxantrone—lymphatic system cancer	0.000944	0.00106	CcSEcCtD
Doxazosin—Feeling abnormal—Carmustine—lymphatic system cancer	0.000941	0.00106	CcSEcCtD
Doxazosin—Fatigue—Vincristine—lymphatic system cancer	0.00094	0.00106	CcSEcCtD
Doxazosin—Asthenia—Bleomycin—lymphatic system cancer	0.000939	0.00106	CcSEcCtD
Doxazosin—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000935	0.00105	CcSEcCtD
Doxazosin—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000934	0.00105	CcSEcCtD
Doxazosin—Constipation—Vincristine—lymphatic system cancer	0.000932	0.00105	CcSEcCtD
Doxazosin—Pain—Vincristine—lymphatic system cancer	0.000932	0.00105	CcSEcCtD
Doxazosin—Pruritus—Bleomycin—lymphatic system cancer	0.000926	0.00104	CcSEcCtD
Doxazosin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000923	0.00104	CcSEcCtD
Doxazosin—Fatigue—Mitoxantrone—lymphatic system cancer	0.000916	0.00103	CcSEcCtD
Doxazosin—Constipation—Mitoxantrone—lymphatic system cancer	0.000908	0.00102	CcSEcCtD
Doxazosin—Pain—Mitoxantrone—lymphatic system cancer	0.000908	0.00102	CcSEcCtD
Doxazosin—Abdominal pain—Carmustine—lymphatic system cancer	0.000903	0.00102	CcSEcCtD
Doxazosin—Body temperature increased—Carmustine—lymphatic system cancer	0.000903	0.00102	CcSEcCtD
Doxazosin—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000892	0.001	CcSEcCtD
Doxazosin—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000892	0.001	CcSEcCtD
Doxazosin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000875	0.000984	CcSEcCtD
Doxazosin—Dysuria—Methotrexate—lymphatic system cancer	0.00087	0.000978	CcSEcCtD
Doxazosin—Neutropenia—Methotrexate—lymphatic system cancer	0.00087	0.000978	CcSEcCtD
Doxazosin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000868	0.000976	CcSEcCtD
Doxazosin—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000865	0.000972	CcSEcCtD
Doxazosin—Abdominal pain—Vincristine—lymphatic system cancer	0.000862	0.000969	CcSEcCtD
Doxazosin—Body temperature increased—Vincristine—lymphatic system cancer	0.000862	0.000969	CcSEcCtD
Doxazosin—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000857	0.000963	CcSEcCtD
Doxazosin—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000849	0.000955	CcSEcCtD
Doxazosin—Urticaria—Mitoxantrone—lymphatic system cancer	0.000844	0.000948	CcSEcCtD
Doxazosin—Hypersensitivity—Carmustine—lymphatic system cancer	0.000842	0.000946	CcSEcCtD
Doxazosin—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000839	0.000944	CcSEcCtD
Doxazosin—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000839	0.000944	CcSEcCtD
Doxazosin—Pneumonia—Methotrexate—lymphatic system cancer	0.000834	0.000938	CcSEcCtD
Doxazosin—Vomiting—Bleomycin—lymphatic system cancer	0.000832	0.000935	CcSEcCtD
Doxazosin—Drowsiness—Methotrexate—lymphatic system cancer	0.00083	0.000933	CcSEcCtD
Doxazosin—Depression—Methotrexate—lymphatic system cancer	0.000827	0.00093	CcSEcCtD
Doxazosin—Rash—Bleomycin—lymphatic system cancer	0.000825	0.000928	CcSEcCtD
Doxazosin—Dermatitis—Bleomycin—lymphatic system cancer	0.000824	0.000927	CcSEcCtD
Doxazosin—Asthenia—Carmustine—lymphatic system cancer	0.00082	0.000921	CcSEcCtD
Doxazosin—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000806	0.000907	CcSEcCtD
Doxazosin—Hypersensitivity—Vincristine—lymphatic system cancer	0.000803	0.000903	CcSEcCtD
Doxazosin—Sweating—Methotrexate—lymphatic system cancer	0.000795	0.000894	CcSEcCtD
Doxazosin—Haematuria—Methotrexate—lymphatic system cancer	0.000791	0.000889	CcSEcCtD
Doxazosin—Epistaxis—Methotrexate—lymphatic system cancer	0.000782	0.00088	CcSEcCtD
Doxazosin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000782	0.00088	CcSEcCtD
Doxazosin—Asthenia—Vincristine—lymphatic system cancer	0.000782	0.00088	CcSEcCtD
Doxazosin—Diarrhoea—Carmustine—lymphatic system cancer	0.000782	0.000879	CcSEcCtD
Doxazosin—Nausea—Bleomycin—lymphatic system cancer	0.000777	0.000874	CcSEcCtD
Doxazosin—Asthenia—Mitoxantrone—lymphatic system cancer	0.000762	0.000857	CcSEcCtD
Doxazosin—Dizziness—Carmustine—lymphatic system cancer	0.000755	0.000849	CcSEcCtD
Doxazosin—Diarrhoea—Vincristine—lymphatic system cancer	0.000746	0.000839	CcSEcCtD
Doxazosin—Hepatitis—Methotrexate—lymphatic system cancer	0.000745	0.000837	CcSEcCtD
Doxazosin—Pharyngitis—Methotrexate—lymphatic system cancer	0.000739	0.000831	CcSEcCtD
Doxazosin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000727	0.000817	CcSEcCtD
Doxazosin—Vomiting—Carmustine—lymphatic system cancer	0.000726	0.000817	CcSEcCtD
Doxazosin—Dizziness—Vincristine—lymphatic system cancer	0.000721	0.000811	CcSEcCtD
Doxazosin—Rash—Carmustine—lymphatic system cancer	0.00072	0.00081	CcSEcCtD
Doxazosin—Dermatitis—Carmustine—lymphatic system cancer	0.00072	0.000809	CcSEcCtD
Doxazosin—Visual impairment—Methotrexate—lymphatic system cancer	0.000718	0.000807	CcSEcCtD
Doxazosin—Headache—Carmustine—lymphatic system cancer	0.000716	0.000805	CcSEcCtD
Doxazosin—Eye disorder—Methotrexate—lymphatic system cancer	0.000696	0.000782	CcSEcCtD
Doxazosin—Tinnitus—Methotrexate—lymphatic system cancer	0.000694	0.000781	CcSEcCtD
Doxazosin—Vomiting—Vincristine—lymphatic system cancer	0.000693	0.000779	CcSEcCtD
Doxazosin—Rash—Vincristine—lymphatic system cancer	0.000688	0.000773	CcSEcCtD
Doxazosin—Dermatitis—Vincristine—lymphatic system cancer	0.000687	0.000772	CcSEcCtD
Doxazosin—Headache—Vincristine—lymphatic system cancer	0.000683	0.000768	CcSEcCtD
Doxazosin—Nausea—Carmustine—lymphatic system cancer	0.000678	0.000763	CcSEcCtD
Doxazosin—Vomiting—Mitoxantrone—lymphatic system cancer	0.000675	0.000759	CcSEcCtD
Doxazosin—Rash—Mitoxantrone—lymphatic system cancer	0.00067	0.000753	CcSEcCtD
Doxazosin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000669	0.000752	CcSEcCtD
Doxazosin—Chills—Methotrexate—lymphatic system cancer	0.000668	0.000751	CcSEcCtD
Doxazosin—Headache—Mitoxantrone—lymphatic system cancer	0.000665	0.000748	CcSEcCtD
Doxazosin—Alopecia—Methotrexate—lymphatic system cancer	0.000658	0.00074	CcSEcCtD
Doxazosin—Mental disorder—Methotrexate—lymphatic system cancer	0.000652	0.000734	CcSEcCtD
Doxazosin—Malnutrition—Methotrexate—lymphatic system cancer	0.000648	0.000729	CcSEcCtD
Doxazosin—Nausea—Vincristine—lymphatic system cancer	0.000648	0.000728	CcSEcCtD
Doxazosin—Dysgeusia—Methotrexate—lymphatic system cancer	0.000635	0.000714	CcSEcCtD
Doxazosin—Nausea—Mitoxantrone—lymphatic system cancer	0.000631	0.000709	CcSEcCtD
Doxazosin—Back pain—Methotrexate—lymphatic system cancer	0.000627	0.000705	CcSEcCtD
Doxazosin—Vision blurred—Methotrexate—lymphatic system cancer	0.000611	0.000687	CcSEcCtD
Doxazosin—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000601	0.000676	CcSEcCtD
Doxazosin—Malaise—Methotrexate—lymphatic system cancer	0.000585	0.000657	CcSEcCtD
Doxazosin—Vertigo—Methotrexate—lymphatic system cancer	0.000582	0.000655	CcSEcCtD
Doxazosin—Leukopenia—Methotrexate—lymphatic system cancer	0.00058	0.000652	CcSEcCtD
Doxazosin—Cough—Methotrexate—lymphatic system cancer	0.000566	0.000636	CcSEcCtD
Doxazosin—Convulsion—Methotrexate—lymphatic system cancer	0.000562	0.000632	CcSEcCtD
Doxazosin—Chest pain—Methotrexate—lymphatic system cancer	0.000552	0.000621	CcSEcCtD
Doxazosin—Arthralgia—Methotrexate—lymphatic system cancer	0.000552	0.000621	CcSEcCtD
Doxazosin—Myalgia—Methotrexate—lymphatic system cancer	0.000552	0.000621	CcSEcCtD
Doxazosin—Discomfort—Methotrexate—lymphatic system cancer	0.000545	0.000613	CcSEcCtD
Doxazosin—Confusional state—Methotrexate—lymphatic system cancer	0.000533	0.0006	CcSEcCtD
Doxazosin—Infection—Methotrexate—lymphatic system cancer	0.000526	0.000591	CcSEcCtD
Doxazosin—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000518	0.000582	CcSEcCtD
Doxazosin—Skin disorder—Methotrexate—lymphatic system cancer	0.000514	0.000578	CcSEcCtD
Doxazosin—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000511	0.000575	CcSEcCtD
Doxazosin—Anorexia—Methotrexate—lymphatic system cancer	0.000504	0.000567	CcSEcCtD
Doxazosin—Hypotension—Methotrexate—lymphatic system cancer	0.000494	0.000556	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000482	0.000542	CcSEcCtD
Doxazosin—Insomnia—Methotrexate—lymphatic system cancer	0.000479	0.000538	CcSEcCtD
Doxazosin—Paraesthesia—Methotrexate—lymphatic system cancer	0.000475	0.000534	CcSEcCtD
Doxazosin—Dyspnoea—Methotrexate—lymphatic system cancer	0.000472	0.00053	CcSEcCtD
Doxazosin—Somnolence—Methotrexate—lymphatic system cancer	0.00047	0.000529	CcSEcCtD
Doxazosin—Dyspepsia—Methotrexate—lymphatic system cancer	0.000466	0.000524	CcSEcCtD
Doxazosin—Decreased appetite—Methotrexate—lymphatic system cancer	0.00046	0.000517	CcSEcCtD
Doxazosin—Fatigue—Methotrexate—lymphatic system cancer	0.000456	0.000513	CcSEcCtD
Doxazosin—Pain—Methotrexate—lymphatic system cancer	0.000452	0.000509	CcSEcCtD
Doxazosin—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000436	0.00049	CcSEcCtD
Doxazosin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000433	0.000486	CcSEcCtD
Doxazosin—Urticaria—Methotrexate—lymphatic system cancer	0.00042	0.000473	CcSEcCtD
Doxazosin—Abdominal pain—Methotrexate—lymphatic system cancer	0.000418	0.00047	CcSEcCtD
Doxazosin—Body temperature increased—Methotrexate—lymphatic system cancer	0.000418	0.00047	CcSEcCtD
Doxazosin—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00039	0.000438	CcSEcCtD
Doxazosin—Asthenia—Methotrexate—lymphatic system cancer	0.00038	0.000427	CcSEcCtD
Doxazosin—Pruritus—Methotrexate—lymphatic system cancer	0.000374	0.000421	CcSEcCtD
Doxazosin—Diarrhoea—Methotrexate—lymphatic system cancer	0.000362	0.000407	CcSEcCtD
Doxazosin—Dizziness—Methotrexate—lymphatic system cancer	0.00035	0.000393	CcSEcCtD
Doxazosin—Vomiting—Methotrexate—lymphatic system cancer	0.000336	0.000378	CcSEcCtD
Doxazosin—Rash—Methotrexate—lymphatic system cancer	0.000334	0.000375	CcSEcCtD
Doxazosin—Dermatitis—Methotrexate—lymphatic system cancer	0.000333	0.000375	CcSEcCtD
Doxazosin—Headache—Methotrexate—lymphatic system cancer	0.000331	0.000373	CcSEcCtD
Doxazosin—Nausea—Methotrexate—lymphatic system cancer	0.000314	0.000353	CcSEcCtD
